XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (5,839,765) $ (5,517,131)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 264,040 272,391
Amortization 2,325 14,492
Amortization of right-of-use assets 148,541 169,680
Inventory reserve 1,770 2,900
Loss on disposal of assets 44,538 0
Share-based compensation expense 122,170 106,526
Changes in operating assets and liabilities:    
Accounts receivable (78,276) (29,702)
Inventory (146,521) (38,811)
Other assets 154,065 255,271
Accounts payable 36,119 (74,957)
Accrued expenses 80,116 (76,959)
Lease liabilities (181,065) (194,235)
Other liabilities 3,119 (23,361)
Net cash used in operating activities (5,388,824) (5,133,896)
Cash flows from investing activities:    
Purchases of property and equipment (71,849) (295,058)
Net cash used in investing activities (71,849) (295,058)
Cash flows from financing activities:    
Proceeds from the issuance of common stock, accompanying warrants and pre-funded warrants in April 2023 Financing 3,899,813 0
Equity issuance costs (547,764) 0
Proceeds from exercise of pre-funded warrants 188 0
Proceeds from common stock issued through ESPP and exercised options 1,697 16,151
Net proceeds from issuance of common stock in connection with at-the-market sales agreement 3,373 0
Payments of deferred offering costs 0 (13,905)
Repayment of note payable (141,298) (228,662)
Payments under lease obligations (12,255) (11,240)
Net cash provided by (used in) financing activities 3,203,754 (237,656)
Net change in cash and cash equivalents (2,256,919) (5,666,610)
Cash and cash equivalents:    
Beginning of period 12,961,936 24,783,029
End of period 10,705,017 19,116,419
Cash paid for:    
Interest 1,870 3,617
Income taxes 0 800
Non-cash investing and financing activities:    
Deferred offering costs included in accounts payable and accrued expenses 0 82,760
Commissions and deferred offering costs relating to proceeds from issuance of common stock 6,163 0
Prepaid insurance financed with promissory notes $ 0 $ 417,841